loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 2024225 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 INSULIN ISOPHANE HUMAN BIOSYNTHETIC (1)

filter

01 NOVO NORDISK CANADA INC (1)

filter

01 SUSPENSION (1)

filter

01 100UNIT/ML (1)

filter

01 Canada (1)

URL Supplier Web Content
SUSPENSION
100UNIT/ML
NOVOLIN GE NPH
Canada
2024225
10ML
Schedule D
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2024225

Looking for CTD TGA MCC DOSSIER APPLICATION 2024225 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is INSULIN ISOPHANE HUMAN BIOSYNTHETIC, with a corresponding application number 2024225 and regulatory information .

proudly manufactured in the

Novo Nordisk's NOVOLIN GE NPH SUSPENSION, medication with 100UNIT/ML of INSULIN ISOPHANE HUMAN BIOSYNTHETIC.

Post Enquiry
POST ENQUIRY